+36.1%
ORLY vs EMR
+58.0%
-21.9%
-23.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -1.3% | +0.6% | -0.6% |
| 7D | -2.1% | -1.2% | -0.9% | -2.0% |
| 30D | -7.6% | -9.4% | +1.8% | -6.9% |
| 3M | -5.5% | +8.6% | -14.1% | -6.2% |
| 6M | -9.7% | +6.7% | -16.4% | -10.4% |
| YTD | -6.2% | +13.1% | -19.3% | -7.6% |
| 1Y | -18.6% | +12.7% | -31.4% | -19.8% |
| All | +36.1% | +58.0% | -21.9% | +33.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling